You drink coffee and feel nothing. Your genes may explain why.

CYP1A2 is an enzyme in your liver that does one job: break down caffeine into metabolites so your body can eliminate it. This enzyme is the gatekeeper for how long caffeine stays active in your bloodstream. If CYP1A2 works efficiently, caffeine is cleared within 3-5 hours. If it doesn’t, caffeine lingers for 8-12+ hours, circulating through your system long after you’ve forgotten you drank coffee.

The *1F variant, carried by roughly 50% of the population, creates a slow-metabolizing version of CYP1A2. People with one or two *1F alleles process caffeine at perhaps half the speed of fast metabolizers. That means a cup of coffee at noon is still active at dinner. A 3 PM espresso might still be in your system at midnight, keeping you awake even though you don’t consciously feel the stimulation. You’re not insensitive to caffeine; you’re drowning in it so gradually that the feeling becomes invisible.

If you’re a slow metabolizer, caffeine accumulates. You drink a cup, finish it, don’t feel anything dramatic, so you drink another. By evening, you’ve consumed what amounts to twice the dose in your system simultaneously. The effect isn’t a jolt; it’s creeping wakefulness, racing thoughts you can’t pin to coffee, and sleep that never comes deep. You wake up still tired because caffeine from the night before hasn’t fully cleared.

ADORA2A encodes the adenosine A2A receptor on your brain cells. This receptor is caffeine’s primary target. Caffeine works by jamming up this receptor so adenosine can’t attach and make you sleepy. If your ADORA2A receptor is sensitive and responsive, caffeine will bind effectively and block adenosine. If your receptor is less responsive, caffeine’s signal gets lost in the noise, and you feel almost nothing.

The C/C variant at rs5751876, found in roughly 10-15% of the population, alters the adenosine receptor’s sensitivity. People carrying the C/C genotype have a receptor that requires more caffeine to activate or may not activate as robustly even with normal amounts. It’s not that your liver isn’t metabolizing caffeine; it’s that your brain isn’t recognizing the signal caffeine is sending.

If you have the C/C variant, drinking more coffee won’t help because the problem isn’t the amount of caffeine in your system; it’s that your adenosine receptors don’t respond to it the way they should. A double shot feels like a single shot would for someone else, or it feels like nothing at all. You’re not lazy or unmotivated; your nervous system genuinely isn’t registering caffeine’s primary mechanism of action.

COMT breaks down dopamine, norepinephrine, and epinephrine. Caffeine’s stimulating effect comes partly from blocking adenosine, but also from boosting catecholamine activity. If your COMT is highly efficient (Val158Met Val/Val genotype), you clear these stress hormones rapidly. If your COMT is slow (Met/Met), you clear them slowly and tend to feel even small increases more intensely. But the relationship to caffeine is paradoxical.

Fast COMT metabolizers, roughly 25% of people with European ancestry, clear catecholamines so quickly that even when caffeine amplifies dopamine and norepinephrine, those signals get mopped up within minutes. You may feel a brief buzz, but the neurological signal dissipates before your conscious mind registers it as “alertness.” The window is too narrow. You drink coffee, your brain spikes dopamine for 10-15 minutes, then your COMT clears it all away, and you’re back to baseline before the ritual of drinking is even finished.

If you’re a fast COMT metabolizer, caffeine’s mood and focus benefits may be almost imperceptible. The chemical reaction happens; your brain doesn’t experience it. You may feel more alert for a few minutes, then confused why the effect vanished. The problem isn’t that caffeine isn’t working biochemically; it’s that the duration of the effect is too short for your conscious experience to register it as meaningful.

SLC6A4 encodes the serotonin transporter, a protein that recycles serotonin back into neurons after it’s been released. Caffeine can affect serotonin signaling, particularly its interaction with adenosine (adenosine normally enhances serotonin release). The 5-HTTLPR short allele variant makes your serotonin signaling less efficient; you reabsorb serotonin more rapidly and may have lower baseline serotonin tone.

Roughly 40% of the population carries at least one short allele of 5-HTTLPR. When you drink caffeine, the normal response is a subtle lift in mood and motivation, partly from dopamine, partly from enhanced serotonin activity. If you’re a short-allele carrier, your serotonin system is already more reserved. Caffeine may not overcome this baseline deficit, so the mood-lifting effect is muted or absent. You get wakefulness without the sense of wellbeing or motivation that typically accompanies caffeine’s stimulation.

The lived experience is that caffeine makes you agitated or gives you racing thoughts without the pleasant alertness. You feel the jittery part but not the happy, motivated part. Some short-allele carriers report that caffeine makes them anxious. This isn’t a sign that you need to quit caffeine entirely; it’s that the serotonin side of the equation is working against you.

MTHFR converts folate into a form your cells can use to make methyl groups, which fuel hundreds of reactions including neurotransmitter synthesis and energy production. Caffeine’s stimulating effect requires adequate cellular energy (ATP) and robust neurotransmitter systems. If your MTHFR is compromised, your cells may not have the baseline energy or neurological capacity to amplify the dopamine and focus signal that caffeine produces.

The C677T variant, carried by roughly 35-40% of the population, reduces MTHFR enzyme efficiency by 40-70% in people with one or two copies. You can eat a perfect diet and still have cells that are functionally depleted of the methyl groups needed to feel caffeine’s effects. Caffeine may be in your bloodstream and hitting your receptors, but your cells don’t have the energetic currency to translate that signal into conscious alertness.

If you have an MTHFR variant and low energy baseline, caffeine’s stimulation lands on a system that’s already struggling to produce ATP. It’s like pressing the accelerator when the engine is running on fumes. You may feel a brief flutter, then nothing, or the effect may be completely absent because your cells lack the energy infrastructure to express the stimulation. The caffeine is doing its job biochemically; your cells just can’t amplify the signal.

VDR encodes the vitamin D receptor, a regulatory protein that controls how your cells respond to vitamin D. Vitamin D is not just a bone nutrient; it’s a neurohormone that regulates dopamine and serotonin signaling. If your VDR is less efficient at binding or expressing vitamin D’s signals (particularly the FokI variant with shorter allele lengths), your dopamine and serotonin systems may be less responsive overall.

The FokI short allele (f allele), found in roughly 30-50% of the population depending on ancestry, creates a less active VDR. When vitamin D signaling is dampened, your dopamine baseline is lower. Caffeine works partly by amplifying dopamine, but if your baseline is already suppressed by poor VDR function and low vitamin D status, caffeine’s effect is amplified onto a quieter signal. You may not feel the dopamine lift because there’s less dopamine to lift.

If you’re carrying the VDR short allele, especially combined with low vitamin D status, caffeine feels like it’s not working because your dopamine tone is too low for caffeine’s amplification to register. It’s not that the neurochemistry is broken; it’s that the volume on dopamine is already turned down before caffeine tries to turn it up.